# Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement

> **NCT02439944** · PHASE2,PHASE3 · TERMINATED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 18 (actual)

## Conditions studied

- Tobacco Use Disorder
- Nicotine Dependence

## Interventions

- **DRUG:** Nicotine patch
- **DRUG:** Nicotine mouthspray

## Key facts

- **NCT ID:** NCT02439944
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** full RCT funded. no need to continue pilot data collection.
- **Last updated:** 2018-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02439944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02439944, "Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02439944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
